| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Renal Physiology, Vol 259, Issue 2 372-F382, Copyright © 1990 by American Physiological Society
ARTICLES |
C. Chatziantoniou, F. H. Daniels and W. J. Arendshorst
Department of Physiology, University of North Carolina, Chapel Hill 27599.
The objective of this study was to test the hypothesis that angiotensin II and thromboxane A2 (TxA2) contribute to the elevated renal vascular resistance observed during the development of genetic hypertension. In 6-wk-old anesthetized spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto (WKY) rats, renal blood flow (electromagnetic flowmetry) and carotid arterial pressure were measured during bolus injections of different doses of angiotensin II and U46619 (stable receptor agonist of TxA2) into the renal artery before and during inhibition of prostaglandin synthesis by indomethacin. In all cases, arterial pressure remained unchanged at the pre-injection levels. Under control conditions, angiotensin II reduced renal blood flow in SHR almost twice as much as in WKY. This strain difference was abolished by inhibition of prostaglandin synthesis, suggesting that a deficiency in the action of endogenous vasodilator prostaglandins is responsible for the enhanced response to angiotensin II in SHR. Under control conditions, the TxA2-receptor agonist produced similar reductions of renal blood flow in SHR and WKY. However, after indomethacin, the agonist-induced vasoconstriction was twice as large in SHR as in WKY, suggesting that SHR kidneys have an increased vascular reactivity to TxA2, which is unmasked when indomethacin reduces elevated levels of endogenous TxA2. These findings indicate important strain differences between young SHR and WKY in the renal vascular response to angiotensin II and TxA2 that may contribute to the renal vasoconstriction observed during the development of genetic hypertension.
This article has been cited by other articles:
|
|
 |
|
  M. M. Sellers and J. N. Stallone Sympathy for the devil: the role of thromboxane in the regulation of vascular tone and blood pressure Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H1978 - H1986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. B. Vagnes, B. M. Iversen, and W. J. Arendshorst Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA2/isoprostane production Am J Physiol Renal Physiol, September 1, 2007; 293(3): F860 - F867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Joly, R. Seqqat, B. Flamion, N. Caron, A. Michel, J. D. Imig, and R. Kramp Increased renal vascular reactivity to ANG II after unilateral nephrectomy in the rat involves 20-HETE Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R977 - R986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. T. de Richelieu, C. M. Sorensen, N.-H. Holstein-Rathlou, and M. Salomonsson NO-independent mechanism mediates tempol-induced renal vasodilation in SHR Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1227 - F1234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Andresen, K. Shome, E. K. Jackson, and G. G. Romero AT2 receptors cross talk with AT1 receptors through a nitric oxide- and RhoA-dependent mechanism resulting in decreased phospholipase D activity Am J Physiol Renal Physiol, April 1, 2005; 288(4): F763 - F770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhao, T. Yamamoto, J. W. Newman, I.-H. Kim, T. Watanabe, B. D. Hammock, J. Stewart, J. S. Pollock, D. M. Pollock, and J. D. Imig Soluble Epoxide Hydrolase Inhibition Protects the Kidney from Hypertension-Induced Damage J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1244 - 1253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. B. Vagnes, F. H. Hansen, R. E. F. Christiansen, C. Gjerstad, and B. M. Iversen Age-dependent regulation of vasopressin V1a receptors in preglomerular vessels from the spontaneously hypertensive rat Am J Physiol Renal Physiol, May 1, 2004; 286(5): F997 - F1003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. C. Kopp, M. Z. Cicha, and L. A. Smith Endogenous angiotensin modulates PGE2-mediated release of substance P from renal mechanosensory nerve fibers Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R19 - R30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Jackson, W. A. Herzer, C. K. Kost Jr, and S. J. Vyas Enhanced Interaction Between Renovascular {alpha}2-Adrenoceptors and Angiotensin II Receptors in Genetic Hypertension Hypertension, September 1, 2001; 38(3): 353 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bautista, A. Sanchez, J. Hernandez, A. Oyekan, and B. Escalante Angiotensin II Type AT2 Receptor mRNA Expression and Renal Vasodilatation Are Increased in Renal Failure Hypertension, September 1, 2001; 38(3): 669 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Salomonsson and W. J. Arendshorst Norepinephrine-induced calcium signaling pathways in afferent arterioles of genetically hypertensive rats Am J Physiol Renal Physiol, August 1, 2001; 281(2): F264 - F272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Vagnes, J. J. Feng, B. M. Iversen, and W. J. Arendshorst Upregulation of V1 receptors in renal resistance vessels of rats developing genetic hypertension Am J Physiol Renal Physiol, June 1, 2000; 278(6): F940 - F948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Welch, A. Tojo, and C. S. Wilcox Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR Am J Physiol Renal Physiol, May 1, 2000; 278(5): F769 - F776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Jackson, W. A. Herzer, Z. Mi, S. J. Vyas, and C. K. Kost Jr Low-Dose Angiotensin II Reduces Urinary Cyclic AMP Excretion in Spontaneously Hypertensive, But Not Normotensive, Rats: Independence from Hypertension and Renal Hemodynamic Effects of Angiotensin J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 115 - 123. [Abstract] [Full Text]
|
|
|
|
|
|
E. K. Jackson, W. A. Herzer, S. J. Vyas, and C. K. Kost Jr Angiotensin II-Induced Renal Vasoconstriction in Genetic Hypertension J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 329 - 334. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Zicha and J. Kunes Ontogenetic Aspects of Hypertension Development: Analysis in the Rat Physiol Rev, October 1, 1999; 79(4): 1227 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Brannstrom and W. J. Arendshorst Thromboxane A2 contributes to the enhanced tubuloglomerular feedback activity in young SHR Am J Physiol Renal Physiol, May 1, 1999; 276(5): F758 - F766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Touyz, M. El Mabrouk, G. He, X-H. Wu, and E. L. Schiffrin Mitogen-Activated Protein/Extracellular Signal–Regulated Kinase Inhibition Attenuates Angiotensin II–Mediated Signaling and Contraction in Spontaneously Hypertensive Rat Vascular Smooth Muscle Cells Circ. Res., March 19, 1999; 84(5): 505 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Brannstrom and W. J. Arendshorst Resetting of exaggerated tubuloglomerular feedback activity in acutely volume-expanded young SHR Am J Physiol Renal Physiol, March 1, 1999; 276(3): F409 - F416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Iversen and W. J. Arendshorst Exaggerated Ca2+ signaling in preglomerular arteriolar smooth muscle cells of genetically hypertensive rats Am J Physiol Renal Physiol, February 1, 1999; 276(2): F260 - F270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Jacinto, J. J. Mullins, and K. D. Mitchell Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats Am J Physiol Renal Physiol, February 1, 1999; 276(2): F315 - F322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Healy and L. Song Kidney Aminopeptidase A and Hypertension, Part I : Spontaneously Hypertensive Rats Hypertension, February 1, 1999; 33(2): 740 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Song and D. P. Healy Kidney Aminopeptidase A and Hypertension, Part II : Effects of Angiotensin II Hypertension, February 1, 1999; 33(2): 746 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cervenka, C.-T. Wang, K. D. Mitchell, and L. G. Navar Proximal Tubular Angiotensin II Levels and Renal Functional Responses to AT1 Receptor Blockade in Nonclipped Kidneys of Goldblatt Hypertensive Rats Hypertension, January 1, 1999; 33(1): 102 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Touyz, D. Endemann, G. He, J.-S. Li, and E. L. Schiffrin Role of AT2 Receptors in Angiotensin II–Stimulated Contraction of Small Mesenteric Arteries in Young SHR Hypertension, January 1, 1999; 33(1): 366 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bischoff, V. Limmroth, and M. C. Michel Indomethacin Inhibits the Natriuretic Effects of Neuropeptide Y in Anesthetized Rats J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 704 - 708. [Abstract] [Full Text]
|
|
|
|
|
|
S. J. Vyas, R. Mokkapatti, R. K. Dubey, M. R. Chinoy, and E. K. Jackson Guanine Nucleotide-Binding Inhibitory Protein-Mediated Inhibition of Adenylyl Cyclase Is Enhanced in Spontaneously Hypertensive Rat Preglomerular Arteriolar Smooth Muscle Cells J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 828 - 834. [Abstract] [Full Text]
|
|
|
|
|
|
J. J. Feng and W. J. Arendshorst Calcium Signaling Mechanisms in Renal Vascular Responses to Vasopressin in Genetic Hypertension Hypertension, November 1, 1997; 30(5): 1223 - 1231. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. Blaze, P. J. Mannon, S. R. Vigna, A. R. Kherani, and B. A. Benjamin Peptide YY receptor distribution and subtype in the kidney: effect on renal hemodynamics and function in rats Am J Physiol Renal Physiol, October 1, 1997; 273(4): F545 - F553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Notoya, M. Nakamura, and K. Mizojiri Effects of Lisinopril on the Structure of Renal Arterioles Hypertension, March 1, 1996; 27(3): 364 - 370. [Abstract] [Full Text]
|
|
|
|
|
|
D. J. Campbell, A.-M. Duncan, A. Kladis, and S. B. Harrap Angiotensin Peptides in Spontaneously Hypertensive and Normotensive Donryu Rats Hypertension, May 1, 1995; 25(5): 928 - 934. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
